Table 1. Clinical details of the studied population.

	HC (n = 275)	AHB (n = 196)	CHB-M (n = 193)	CHB-S (n = 188)	P value
Gender (M/F)	156/30	149/47	153/40	155/33	0.259
Age (years)	31.2±10.2	35.4±12.4	32.4±14.1	38.7±13.2	<0.001
Total bilirubin (µmol/L)	–	111.4±89.4	11.7±5.8	185.8±192.4	<0.001
Prothrombin activity (%)	–	95.1±24.9	93.5±19.7	81.6±20.0	<0.001
Albumin (g/L)	–	39.0±3.8	43.1±3.5	37.3±4.2	<0.001
Albumin/globulin	–	1.65±0.4	1.73±0.3	1.50±0.3	<0.001
Cholinesterase (IU/L)	–	5544.5±1746.6	7171.1±2324.0	4233.2±1548.8	<0.001
ALT (IU/L)	–	648.3±830.3	80.3±124.0	416.0±389.9	<0.001
HBV DNA (logcps/mL)	–	3.88±1.46	5.31±2.16	5.68±1.56	<0.001
HBeAg negative/positive	–	137/59	146/47	100/88	<0.001

HC, healthy controls; AHB, acute hepatitis B; CHB-M, mild chronic hepatitis B; CHB-S, severe chronic hepatitis B.